RWM
BSX icon

Ritholtz Wealth Management’s Boston Scientific BSX Stock Holding History

Ritholtz Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12M Sell
33,734
-4,400
-12% -$352K 0.04% 366
2025
Q4 		$3.64M Sell
38,134
-151
-0.4% -$14.8K 0.07% 214
2025
Q3 		$3.74M Buy
38,285
+2,001
+6% +$207K 0.07% 184
2025
Q2 		$3.9M Buy
36,284
+1,225
+3% +$124K 0.09% 146
2025
Q1 		$3.54M Buy
35,059
+2,413
+7% +$243K 0.11% 132
2024
Q4 		$2.92M Buy
32,646
+4,050
+14% +$357K 0.09% 150
2024
Q3 		$2.4M Buy
28,596
+5,303
+23% +$418K 0.07% 191
2024
Q2 		$1.79M Buy
23,293
+3,643
+19% +$267K 0.06% 223
2024
Q1 		$1.35M Sell
19,650
-2,205
-10% -$142K 0.05% 286
2023
Q4 		$1.26M Buy
21,855
+1,208
+6% +$64.5K 0.05% 258
2023
Q3 		$1.09M Buy
20,647
+1,440
+7% +$75.5K 0.05% 252
2023
Q2 		$1.04M Buy
19,207
+2,153
+13% +$112K 0.05% 263
2023
Q1 		$853K Buy
17,054
+11,538
+209% +$544K 0.04% 297
2022
Q4 		$255K Sell
5,516
-13,279
-71% -$575K 0.01% 486
2022
Q3 		$728K Buy
+18,795
New +$754K 0.04% 312

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ritholtz Wealth Management's BSX Position: Q1 2026 in Review

Ritholtz Wealth Management reduced its Boston Scientific (BSX) stake by 12% in Q1 2026, selling an estimated $352K and leaving 33,734 shares worth $2.12M. The position accounts for 0.04% of the portfolio, ranked #366.

Ritholtz Wealth Management first reported a position in BSX in Q3 2022 and has held it in 15 quarters since. The position peaked at $3.9M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Ritholtz Wealth Management held 33,734 shares of Boston Scientific worth $2.12M as of Q1 2026.
  • Ritholtz Wealth Management sold 4,400 Boston Scientific shares in Q1 2026, an estimated $352K.
  • Boston Scientific made up 0.04% of Ritholtz Wealth Management's portfolio in Q1 2026, its #366 holding.
  • Ritholtz Wealth Management first reported a position in Boston Scientific in Q3 2022 and has held it in 15 quarters since.
  • Ritholtz Wealth Management's Boston Scientific position peaked at $3.9M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.